AB 463
10 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| David Chiu | Sponsors | David Chiu sponsored AB 463. | None |
| Biogen Ma Inc. | Lobbied on it | Biogen Ma Inc. named AB 463 in 5 lobbying reports. | 5 reports |
| Otsuka America Pharmaceutical, Inc. | Lobbied on it | Otsuka America Pharmaceutical, Inc. named AB 463 in 5 lobbying reports. | 5 reports |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Lobbied on it | Boehringer Ingelheim Pharmaceuticals, Inc. named AB 463 in 4 lobbying reports. | 4 reports |
| Biotechnology Innovation Organization | Lobbied on it | Biotechnology Innovation Organization named AB 463 in 4 lobbying reports. | 4 reports |
| California Life Sciences | Lobbied on it | California Life Sciences named AB 463 in 4 lobbying reports. | 4 reports |
| Celgene Corporation | Lobbied on it | Celgene Corporation named AB 463 in 4 lobbying reports. | 4 reports |
| Takeda Pharmaceuticals America | Lobbied on it | Takeda Pharmaceuticals America named AB 463 in 4 lobbying reports. | 4 reports |
| Amgen | Lobbied on it | Amgen named AB 463 in 3 lobbying reports. | 3 reports |
| Pharmaceutical Cost Transparency Act of 2016. | Source records | AB 463 has an explicit source reference to Pharmaceutical Cost Transparency Act of 2016.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…